Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

B. Baumert, M. Hegi, M. van den Bent, A. von Deimling, T. Gorlia, K. Hoang-Xuan, A. Brandes, G. Kantor, M. Taphoorn, M. Hassel, C. Hartmann, G. Ryan, D. Capper, J. Kros, S. Kurscheid, W. Wick, R. Enting, M. Reni, B. Thiessen, F. Dhermain, J. Bromberg, L. Feuvret, J. Reijneveld, O. Chinot, J. Gijtenbeek, J. Rossiter, N. Dif, C. Balana, J. Bravo-Marques, P. Clement, C. Marosi, T. Tzuk-Shina, R. Nordal, J. Rees, D. Lacombe, W. Mason, and R. Stupp. Lancet Oncol, 17 (11): 1521-1532 (November 2016)
DOI: 10.1016/S1470-2045(16)30313-8

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Graham Capper

John Capper

David Mark Capper

D Böttger

D Zeppenfeld

Other publications of authors with the same name

Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyE. Pfaff, T. Kessler, G. Balasubramanian, A. Berberich, D. Schrimpf, A. Wick, J. Debus, A. Unterberg, M. Bendszus, C. Herold-Mende and 11 other author(s). Neuro Oncol, 20 (6): 826-837 (May 2018)cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutantD. Louis, C. Giannini, D. Capper, W. Paulus, D. Figarella-Branger, M. Lopes, T. Batchelor, J. Cairncross, M. van den Bent, W. Wick and 1 other author(s). Acta Neuropathol, 135 (4): 639-642 (April 2018)Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasC. Hartmann, J. Meyer, J. Balss, D. Capper, W. Mueller, A. Christians, J. Felsberg, M. Wolter, C. Mawrin, W. Wick and 7 other author(s). Acta Neuropathol, 118 (4): 469-474 (October 2009)WHO 2016 Classification of GliomasP. Wesseling, and D. Capper. Neuropathol Appl Neurobiol, (August 2017)Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyB. Baumert, M. Hegi, M. van den Bent, A. von Deimling, T. Gorlia, K. Hoang-Xuan, A. Brandes, G. Kantor, M. Taphoorn, M. Hassel and 27 other author(s). Lancet Oncol, 17 (11): 1521-1532 (November 2016)Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsF. Sahm, D. Schrimpf, D. Jones, J. Meyer, A. Kratz, D. Reuss, D. Capper, C. Koelsche, A. Korshunov, B. Wiestler and 18 other author(s). Acta Neuropathol, 131 (6): 903-910 (June 2016)Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasN. Sabha, C. Knobbe, M. Maganti, S. Al Omar, M. Bernstein, R. Cairns, B. Çako, A. von Deimling, D. Capper, T. Mak and 7 other author(s). Neuro Oncol, 16 (7): 914-923 (July 2014)Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entitiesD. Reuss, A. Kratz, F. Sahm, D. Capper, D. Schrimpf, C. Koelsche, V. Hovestadt, M. Bewerunge-Hudler, D. Jones, J. Schittenhelm and 17 other author(s). Acta Neuropathol, 130 (3): 407-417 (September 2015)ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastomaD. Reuss, F. Sahm, D. Schrimpf, B. Wiestler, D. Capper, C. Koelsche, L. Schweizer, A. Korshunov, D. Jones, V. Hovestadt and 9 other author(s). Acta Neuropathol, 129 (1): 133-146 (January 2015)WHO 2016 Classification of gliomasP. Wesseling, and D. Capper. Neuropathol Appl Neurobiol, 44 (2): 139-150 (February 2018)

BibSonomy

Disambiguation of "Capper, D"

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Please choose a person to relate this publication to

Graham Capper

John Capper

David Mark Capper

D Böttger

D Zeppenfeld

Other publications of authors with the same name

Disambiguation

BibSonomy

Disambiguation of "Capper, D"

copydeleteadd this publication to your clipboardcommunity posthistory of this postURLDOIBibTeXEndNoteAPAChicagoDIN 1505HarvardMSOffice XML Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Please choose a person to relate this publication to

Graham Capper

John Capper

David Mark Capper

D Böttger

D Zeppenfeld

Other publications of authors with the same name

Disambiguation